Medical emergency? Call 112 or your local emergency number immediately.

New flu strain this winter in the EU

Which flu strain is going around Europe right now, and is it worse?

A(H1N1)pdm09 is the dominant flu virus in the EU in ERVISS week 43, and the viruses sequenced so far belong to subclade D.3.1.1. Activity is still low: 2.8% of sentinel samples were positive, down from 4.7%. No nickname exists yet, and neither ECDC nor WHO has called it more severe. The updated vaccine mostly matches, and antivirals still work when started within 48 hours.

New flu strain this winter in the EU
Medically reviewed

Dr. Chrysoula I. Liakou MD, PhD Google Scholar LinkedIn

Internal Medicine Specialist
Cancer Immunology Researcher

Which new flu strain is going around Europe right now?

The new flu strain this winter is A(H1N1)pdm09 subclade D.3.1.1. A(H1N1)pdm09 now dominates in the EU/EEA, and nearly every virus sequenced in England and the United States belongs to D.3.1.1. Activity is still low: 2.8% of sentinel samples were positive in ERVISS week 43, down from 4.7%. No agency has called it more severe.

What is the dominant flu strain in Europe this week?

A(H1N1)pdm09 is the dominant flu strain in Europe in ERVISS week 43 (19 to 25 October 2026), and activity is low. ECDC's wording for the week is short: “Influenza and RSV activities remain low”. Of the sentinel influenza A viruses subtyped since week 40, 138 of 185 (75%) were A(H1N1)pdm09. That is the reverse of last winter, when A(H3N2) led.

The H1N1 viruses being sequenced belong to a single group, subclade D.3.1.1 of clade 5a.2a.1. That covers every sequenced A(H1N1)pdm09 virus in England so far (UKHSA, 29 October 2026). In the United States it covers 354 of 355 characterised viruses (CDC, 30 October 2026).

RSV is barely moving, at 0.4% positivity in the same sentinel samples. SARS-CoV-2 is busier, at 14.6%, and ECDC notes that its circulation “continues to increase in several countries”. Our page on COVID-19 symptoms and treatment covers that virus.

Is there a bad flu going around this winter?

Not on current evidence. Neither ECDC nor WHO has published a severity assessment of D.3.1.1. With 42 sentinel detections across the whole EU/EEA in week 43, there is little yet to assess. CDC's current line is that it is “too early to know what viruses may predominate” this season.

Last winter the equivalent WHO/Europe wording for subclade K was that “there is no evidence that it causes more severe disease”.

What people are calling it

There is no nickname yet. As of 2 November 2026 no health agency has given this autumn's H1N1 a popular name, and none has stuck in the press. The labels in circulation are technical: “A(H1N1)pdm09”, “subclade D.3.1.1” and “G155E”, the single surface-protein change virologists are watching.

A few US outlets say “mutated swine flu”: A(H1N1)pdm09 descends from the 2009 pandemic virus but has been a routine seasonal strain since.

Last winter's name was “super flu”. Journalists coined it for A(H3N2) subclade K in December 2025, after WHO/Europe said the strain made up “up to 90% of all confirmed influenza cases in the European Region”. The same statement said “there is no evidence that it causes more severe disease”. The nickname carried the first fact and dropped the second.

That is why nicknames mislead: a name describes a headline, not your risk. Last winter the answers were reassuring: no evidence of more severe disease, a vaccine that still lowered the risk of severe outcomes, no loss of antiviral sensitivity.

What is different about the new H1N1 strain?

The change is antigenic drift. Small mutations build up and let the virus slip past some of the immunity from earlier seasons. Three things are new this autumn: the subtype, one mutation and the vaccine.

The subtype has flipped. Subclade K is still circulating but outnumbered in every system that publishes sequences. In the United States 98.9% of influenza A viruses subtyped in week 42 were A(H1N1)pdm09.

One mutation is under the microscope. A subset of D.3.1.1 viruses carry G155E, a single change at position 155 of the haemagglutinin, the surface protein that antibodies lock onto. A US laboratory group tested blood from 355 people collected between April and August 2026 against 148 influenza viruses. D.3.1.1 viruses with this kind of change were neutralised less well, most clearly in teenagers and young adults.

The work is a preprint posted in September 2026 and has not yet been peer reviewed. UKHSA, citing WHO ferret-antisera results, reports “low reactivity of some viruses within the D.3.1.1 subclade”. It says it “is not yet clear how vaccine effectiveness against clinical disease may be affected by these observations”.

The vaccine was updated. WHO set the 2026/27 northern-hemisphere composition on 27 February 2026 with a new H1N1 reference virus, A/Missouri/11/2025, alongside A/Darwin/1454/2025 (H3N2) and B/Tokyo/EIS13-175/2025 (B/Victoria). How well it matches the new strain is covered below.

Measure Winter 2025/26 Autumn 2026
Dominant virus A(H3N2) subclade K (formerly J.2.4.1) A(H1N1)pdm09 subclade D.3.1.1
EU/EEA season start Passed 10% in week 46, three to four weeks before the two prior seasons 2.8% in week 43; threshold not reached
Agency severity line WHO/Europe: “no evidence that it causes more severe disease” None published yet
Vaccine Mismatch with subclade K; still lowered the risk of severe outcomes H1N1 component updated; 94.2% of US H1N1 viruses well recognised
Antivirals No reduced susceptibility found in A(H3N2) 1.5% of US viruses with reduced inhibition by one antiviral; none to the others

What are the flu symptoms this year?

Flu starts fast; this year's virus is no exception. The NHS description matches what our doctors see over video: symptoms “come on very quickly”. Typical signs are a sudden high temperature, an aching body, exhaustion, a dry cough, a sore throat, a headache, poor sleep and loss of appetite.

Speed is the tell: flu arrives “within a few hours” while a cold builds “over 1 to 2 days”. Nothing in the current ECDC, UKHSA or CDC reports describes a new symptom pattern for D.3.1.1.

The one-line split our doctors use:

  • Cold: gradual, nose and throat, you can still function.
  • Flu: sudden, fever, aches, exhaustion, floored within hours.
  • COVID-19: can look like either; a test separates it from flu, symptoms alone do not.

The full comparison, with what each test can tell you, is in our cold, flu or COVID-19 comparison. Adults who suspect RSV can read our page on RSV in adults.

Can you get a rapid flu test at a pharmacy in Europe?

Yes, in several served countries. You can test for flu, COVID-19 and RSV with one swab at many European pharmacies. In France, pharmacists may perform rapid tests for influenza, COVID-19 and RSV, alone or combined, in the pharmacy itself. In Germany, combined self-test kits are sold over the counter in pharmacies.

Austrian and Dutch pharmacies and drugstores list them too. Elsewhere, ask for a “combi” or “triplex” kit, which reports each virus on its own line.

Test early. A rapid test is most useful in the first two days, because a positive result then changes what a doctor can do. Antiviral treatment works best when started within 48 hours of the first symptoms.

Our doctors never read a negative rapid test as proof you do not have flu. They weigh it against your symptoms, the timeline and the week's local positivity.

Do antivirals still work against this strain?

Yes, on current evidence. The drugs still work against the viruses tested this season, and timing matters more than the strain. Three antivirals are authorised for influenza in Europe, all prescription-only. ECDC's guidance is that they “should be taken within the first 48 hours of the symptom onset”.

CDC tested 537 influenza viruses collected in the United States since late May 2026. Eight A(H1N1)pdm09 viruses (1.5%) showed reduced inhibition by one of the drugs, and none by the others (CDC, 30 October 2026). UKHSA has recorded five detections of resistance-linked mutations in England so far this season, split between two of the three drugs.

Antivirals are often reserved for people at risk of complications. Our doctors prescribe an antiviral when it is appropriate: a patient in a risk group whose symptoms began within the last two days.

Outside a risk group our doctors advise self-care: rest and sleep, plenty of water, and paracetamol or ibuprofen for the fever and aches. Antibiotics do not work on flu.

Who qualifies in each European country, and what the three drugs do, is in our guide to flu antivirals in Europe. A longer guide to the first week is in how to recover from flu faster. Our approach is on our flu treatment over video page.

Does this year's flu vaccine match, and is it too late?

Mostly, and no, it is not too late. In CDC's latest testing, 97 of 103 (94.2%) A(H1N1)pdm09 viruses were well recognised by antisera to the new H1N1 reference virus. UKHSA's low-reactivity finding, above, leaves the effect on effectiveness unclear. Neither WHO nor ECDC has published a match statement for this season.

Last winter's vaccine was a clear mismatch for subclade K. ECDC's assessment described “a mismatch between the vaccine and this new subclade” and still expected protection against severe disease. WHO/Europe still reported that the vaccine “lowers the risk of severe health outcomes” from that virus.

The European season has not started in earnest. Last winter EU/EEA sentinel positivity passed 10% in week 46, three to four weeks earlier than the two previous seasons. It peaked at 47% in the last week of December and was still above 27% in week 6 of February. ECDC's advice last November was that vaccination “should proceed without delay”; nothing in this season's data changes that.

Mobi Doctor does not vaccinate: our doctors work over video and cannot give an injection. A pharmacy or local GP can. Our guide to getting a flu jab in Europe lists where it is given and who gets it free in all 12 countries.

Where is flu right now in Europe?

Flu activity is still low across the twelve countries Mobi Doctor serves, with Ireland and Romania the highest. The lines below are the ERVISS week 43 sentinel figures, published by ECDC on 30 October 2026. The current week's figures are on our live flu tracker for Europe, updated each Friday.

EU/EEA overall: 2.8%, ↓ from 4.7%. For scale, the same week read 4.9% last year, 1.8% in 2024 and 1.9% in 2023. Sentinel samples are small in some countries, so one week can swing on a few swabs.

How long is flu contagious?

Roughly the first five days are the risky ones. The NHS puts it plainly: “You're more likely to give it to others in the first 5 days after getting infected”. Our calculator on how long flu stays contagious works it out from your symptom start date.

When to see a doctor

Call 112 at once if you or someone with you has sudden chest pain, severe difficulty breathing (gasping, choking or unable to speak), or is coughing up blood. These are the NHS emergency signs for flu; a video consultation is the wrong place for them.

See a doctor promptly, over video or in person, if you have flu symptoms and any of these apply:

  • you are 65 or over
  • you are pregnant or recently gave birth
  • you have a long-term condition, such as diabetes or heart, lung, liver, kidney, brain or nerve disease
  • you have a weakened immune system, for example from chemotherapy or HIV
  • you feel very unwell or short of breath
  • your symptoms have not improved after 7 days

For the risk groups the 48-hour antiviral window is the reason not to wait. A cough that outlasts the flu is covered in our guide to pneumonia after flu.

Children: Mobi Doctor sees adults only. A child with flu who worries you, above all over breathing, drowsiness or not drinking, needs the local paediatric service or 112. Hotel reception or the nearest pharmacy can point you to it.

What a video doctor can do

Our doctors see patients over video usually within 15 minutes, daily 7am–11pm CET, in all twelve countries listed above. Over video the doctor takes your history, watches how you breathe and speak, and checks when your symptoms started against the 48-hour window.

The doctor asks about risk factors and any rapid test result, and screens for the warning signs above. A prescription, when appropriate, is sent to a pharmacy you choose. Outside a risk group, or past 48 hours, the honest advice is usually self-care and a clear list of signs to watch.

What a video doctor cannot do: listen to your chest, measure your oxygen, X-ray, swab or vaccinate you. If you are breathless at rest, have chest pain or are getting worse after a week, you need to be seen in person. Where to go in each country is in our guide to urgent care across Europe.

See available times

Your plan if flu hits mid-trip

Note the hour your first symptom started; the 48-hour clock runs from there. Pick up a combined rapid test early. If you are in a risk group, or the test is positive, speak to a doctor over video before the window closes. Otherwise rest, drink and keep your distance for the first five days.

Pharmacies and surgeries keep different hours over the holidays. Our guide to finding a pharmacy or doctor over Christmas covers the holiday weeks.

See available times

Sources

Written by the Mobi Doctor Medical Team. Medical review by Dr Chrysoula Liakou, MD, PhD: pending.



Frequently asked questions

It has no popular name yet. The technical labels are influenza A(H1N1)pdm09, subclade D.3.1.1, and G155E for the single surface-protein change some of these viruses carry. A few US outlets have used “mutated swine flu”, because the virus descends from the 2009 pandemic strain. If a nickname sticks, the agencies' own labels above are still the ones to search for.

“Super flu” was the December 2025 press name for A(H3N2) subclade K, which drove an early, intense European season. Subclade K is still circulating, but this autumn it is outnumbered by A(H1N1)pdm09 D.3.1.1 in the EU/EEA, England and the United States. No nickname has been attached to the new H1N1 so far.

There is no evidence either way yet. Neither ECDC nor WHO has published a severity assessment for subclade D.3.1.1, and CDC says it is too early to know which viruses will predominate. European case numbers are too small to judge. Last winter's subclade K also showed no evidence of more severe disease, despite its nickname.

No. Our doctors never read a negative rapid test as proof you do not have flu. They weigh it against your symptoms, the timeline and the week's local positivity. Rapid tests are most useful in the first two days, when a positive result changes what a doctor can offer. Combined flu, COVID-19 and RSV kits are sold in many pharmacies.

G155E is a single change at position 155 of the haemagglutinin, the surface protein antibodies lock onto, found in a subset of this autumn's D.3.1.1 viruses. A US preprint posted in September 2026 found these viruses were neutralised less well by blood from 355 people, most clearly in teenagers and young adults. It has not yet been peer reviewed.

No. Last winter EU/EEA flu positivity passed 10% in week 46 and peaked at 47% in the last week of December, so a jab in November still covers most of the season. When flu arrived early last November, ECDC's advice was to vaccinate without delay. Mobi Doctor does not vaccinate; a pharmacy or local GP can.

Key Takeaways

  • A(H1N1)pdm09 dominates EU/EEA flu in ERVISS week 43 (ECDC, 30 October 2026); every virus sequenced in England and 354 of 355 in the US are subclade D.3.1.1.
  • Since week 40, 138 of 185 sentinel influenza A viruses subtyped in the EU/EEA were A(H1N1)pdm09, the reverse of last winter's A(H3N2) season.
  • No nickname exists yet; last winter's “super flu” was A(H3N2) subclade K, which WHO/Europe said showed no evidence of more severe disease.
  • WHO updated the H1N1 vaccine component for 2026/27; CDC found 94.2% of A(H1N1)pdm09 viruses well recognised by antisera to the new reference virus.
  • Antivirals work best within 48 hours of the first symptoms (ECDC); only 1.5% of 537 US viruses showed reduced inhibition by one drug (CDC, 30 October 2026).
  • Last winter EU/EEA flu positivity passed 10% in week 46 and peaked at 47% in the last week of December, so a November jab still covers most of the season.


Comments

Log in to comment


Swipe up to see a Dr.

close